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bstract
We investigated whether the val158met functional polymorphism of catechol-o-methyltransferase influenced age-related changes in grey
atter density and volume, both in healthy individuals (n = 80, ages 18–79) and those with Parkinson’s disease (n = 50). Global grey matter
olumes and voxelwise estimates of grey matter volume and density were determined from structural magnetic resonance images at 3 T. Male
nd female ValVal homozygotes (low prefrontal cortical dopamine) had more grey matter in early adulthood, but this difference disappeared
ith increasing age. The insula and ventral prefrontal cortex had higher grey matter volume in younger, but not older, ValVal homozygotes.
onversely, the dominant premotor cortex revealed genotypic differences in grey matter density in later life. There were no global or local
nteractions between Parkinson’s disease and COMT val158met genotype on morphometry. Since the val158met polymorphism is associated
ith differences in cortical dopamine metabolism, our data suggest a role for dopamine in cortical development followed by differential
ulnerability to cortical atrophy across the adult life span.
2008 Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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. Introduction
Dopamine is one of the most important regulators of brain
unction. In adults it is closely associated with affective and
xecutive cognitive functions, especially of the frontal lobes
nd basal ganglia, and it is central to the pathophysiology of
arkinson’s disease and schizophrenia. Dopamine also influ-
nces cortical neuronal development (Krasnova et al., 2007;
herren and Pappas, 2005) and apoptosis (Iwatsubo et al.,
007). This raises the possibility of structural as well as func-
ional consequences of chronic differences in dopaminergic
unction.
∗ Corresponding author at: Medical Research Council Cognition and Brain
ciences Unit, 15 Chaucer Road, Cambridge CB2 7EF, UK. Tel.: +44 1223
73 630; fax: +44 1223 359 062.
E-mail address: james.rowe@mrc-cbu.cam.ac.uk (J.B. Rowe).
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197-4580/© 2008 Elsevier Inc. This is an open access article under the CC BY liclthy aging; MRI
Chronic differences in cortical dopamine arise in part
rom functional polymorphisms in the gene for membrane
ound catechol-o-methyltransferase (COMT) the principal
atabolic enzyme for cortical dopamine (Yavich et al., 2007).
n contrast, COMT contributes little to striatal dopamine
atabolism (Tunbridge et al., 2004). The substitution of valine
Val) by methionine (Met) at codon 158 causes a trimodal
istribution of enzymatic activity: ValVal vs. ValMet vs.
etMet. Functionally, this is the most significant of the
any COMT polymorphisms. There is evidence of structural
ffects of this val158met polymorphism in specific groups,
.g. Val-hemizygote men with velo-cardio-facial syndrome
van Amelsvoort et al., 2008) and adults with schizophre-
ia or a high risk of schizophrenia (McIntosh et al., 2007;
hnishi et al., 2006).
In Parkinson’s disease (PD) motor and cognitive
ymptoms are also associated with chronic dopamine abnor-
alities within the cortex (Nagano-Saito et al., 2004; Rakshi
ense (http://creativecommons.org/licenses/by/3.0/).
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t al., 1999) even though striatal pathology develops ahead of
ortical pathology (Braak et al., 2006). Even in early PD, the
al158met COMT polymorphism influences executive func-
ions that are mediated by frontal cortex (Williams-Gray
t al., 2008). The question arises therefore whether there
re common effects of the val158met polymorphism and
D, e.g. do the cortical dopamine hypermetabolism in early
D and the hyperdopaminergic state of MetMet homozy-
otes have similar influences on cortical structure, or do they
nteract?
The effects of PD and COMT must be interpreted in the
ight of age related changes in grey matter morphometry
Good et al., 2001). However, the effect of the val158met
olymorphism on age-related atrophy has not yet been iden-
ified across the adult lifespan. We therefore studied total
rey matter volume in adults with and without PD aged
8–79 years. We then analysed regional changes in grey mat-
er volume and density. We hypothesised that the val158met
olymorphism interacts with global and regional rates of atro-
hy. We secondly hypothesised that such interactions would
e influenced by the chronic dopaminergic abnormalities
n PD.
. Methods
.1. Subjects
Eighty-two healthy adults participated, with no current
eurological or psychiatric history (bimodal age distribution:
ld: 51–78, mean 66.2, S.D. 7.3, MMSE 29.2; and young:
0–47, mean 25.6, S.D. 6.7). Fifty patients with Parkinson’s
isease were recruited from the Cambridge PD Research
linic (UK Parkinson’s Disease Society Brain Bank clinical
iagnostic criteria), 50–80 years (mean 64.9, S.D. 9); with no
urrent depression (Beck Depression Inventory II score <13)
r dementia (clinical diagnostic criteria and recent MMSE
27). See supplementary Table S1 for patient subgroup char-
cteristics.
.2. Genotype
DNA was extracted from peripheral blood samples using
tandard phenol/chloroform methods (Williams-Gray et al.,
007). The val158met genotype was determined by allelic dis-
rimination TaqMan assays. This generates an allele-specific
uorescent reporter signal using the 5′ exonuclease activity of
aq polymerase. This signal was measured after PCRs using
he HT7900 detection system (Applied Biosystems, Foster
ity, CA).
.3. MRI dataMRI used a high resolution MPRAGE sequence
TR 2250 ms, TE 2.99 ms, FA 9 degrees, IT 900 ms,
56 × 256 × 192 isotropic 1 mm voxels) with a Siemens
a
G
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im Trio 3 Tesla scanner. Pre-processing used SPM5
oftware (fil.ion.ucl.ac.uk/spm) and its VBM toolbox
dbm.neuro.uni-jena.de/vbm) with Matlab 7 (Mathworks,
SA). Data underwent an iterative unified segmentation nor-
alisation procedure (Ashburner and Friston, 2005) into
hree tissue segments (GM, WM, CSF) with bias correction
nd warping to the Montreal Neurological Institute T1 tem-
late. The Hidden Markov Random Fields model was applied
o constrain voxelwise segmentation based on nearest neigh-
ours (Cuadra et al., 2005). The normalised modulated and
nmodulated images of grey matter (GM) were smoothed by
n isotropic Gaussian kernel (FWHM 16 mm).
Global GM volume was analysed in SPSS 11.0 (Chicago,
ll). We used a stepwise linear regression model including
ge, sex, val158met genotype, disease (PD vs. control), the 2-
ay interactions (‘age × genotype’, ‘age × sex’, ‘genotype ×
ex’, ‘disease group × age’, ‘disease group × genotype’) 3-
ay interactions and a constant term.
Voxel based morphometry (Ashburner and Friston, 2000)
sed general linear models to characterise the effects of
OMT (ValVal, ValMet or MetMet), age and PD on differ-
nces in regional grey matter density (unmodulated images)
nd volume (modulated images). The models included
egressors that separately specified each COMT subgroup
ValVal, ValMet, MetMet) for patients, older controls (>50)
nd younger controls (<50)(see supplementary Fig. S1) and
otal GM volume as a covariate. In addition, linear and
uadratic functions of the UPDRS were included for each
ubgroup of patients.
Because of the predominant frontal distribution of cortical
opamine and the evidence of COMT modulation of frontal
ortical functions, we restricted our study to a frontal lobe
egion of interest (supplementary Fig. S2) including all the
rontal lobe regions and striatum as defined by Anatomical
utomatic Labelling in MNI space (Tzourio-Mazoyer et al.,
002). We corrected for local smoothness and multiple com-
arisons (family wise error rate FWE p < 0.05). Additional
esults of interest are presented at the secondary threshold
< 0.001 unc.
. Results
.1. Global GM volume
Fig. 1 shows the adjusted GM volume changes with age
or the three genotypic groups of participants: ValVal, ValMet
nd MetMet. Stepwise linear regression indicated three sig-
ificant variables: age (t(126) = −14.0, p < 0.001, rate = 0.4%
er year), sex (t(126) = −6.60, p < 0.001, 6.7% difference)
nd the interaction between age and genotype (t(126) = 2.28,
< 0.05, global atrophy rate difference between ValVal
nd MetMet 0.16% per year) accounting for 67% of
M volume variance (r = 0.823, F 3,126 = 88, p < 0.001).
xcluded factors had t-statistics in the range −0.6 < t < 0.6
p > 0.5) except ‘disease × age’ (t = −1.3, p = 0.20). The
1066 J.B. Rowe et al. / Neurobiology of A
Fig. 1. Global GM volume changes with age in ValVal (red), ValMet (green)
and MetMet (black) groups for healthy subjects and patients with Parkinson’s
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fisease (adjusted for gender differences). Lines indicate least squares linear
egression trends.
olerances (>0.99) and variance inflation factors (<1.01) were
ood.
A post hoc unpaired t-test of sex adjusted GM data from
oung subjects (age < 50) confirmed that ValVal subjects
ad more GM volume than MetMet subjects (t(17) = 2.32,
-tailed p < 0.05). Because of collinearity between dis-
ase (PD) and age, a subsidiary analysis was run using
ata from the older subjects only (age > 50, n = 100).
his supported a reduced model that included just age
nd sex as significant factors. Age was highly significant
t(98) = −3.74, p < 0.001, effect 0.36% per year) as was sex
t(98) = −5.73,p < 0.001, 8.2% difference). The effects of
age × genotype’ (t(98) = −0.92) disease (t(98) = −0.05) and
enotype (t(98) = 0.2) were not significant.
y
(
ig. 2. SPM{t} maps of voxelwise morphometric interactions in healthy subjects
ith age (FWE p < 0.05) and (B) GM volume differences reducing with age (p < 0.0
n premotor cortex (MNI x,y,z = −12 −8 71) are plotted against age for ValVal (red
rontal operculum/insula (MNI x,y,z = −33, 28, 1) are plotted against age for ValVaging 31 (2010) 1064–1068
.2. Regionally speciﬁc changes in GM density
There were extensive differences between older and
ounger healthy subjects collapsed across genotype (contrast
zeros(1,9) −1 −1 −1 1 1 1]). Younger subjects had higher
ensity in medial and lateral prefrontal cortex, dorsally and
entrally, and the caudate nuclei (supplementary Fig. S3A).
Across the whole group, there were no signifi-
ant regional differences between ValVal vs. MetMet
roups (SPM{t}contrast ± [1 0 0 0 0 0 −1 0 0 1 0 −1 1 0 −1]
r SPM{F} contrast [1 0 0 0 0 0 −1 0 0 1 0 −1 1 0 −1;
0 0 1 0 0 −1 0 0 0 1 −1 1 0 −1]). An interaction between
enotype and aging was identified in the left premotor
ortex (contrast [1 0 0 0 0 0 −1 0 0 1 0 −1 −2 0 2], peak
14,−10,70, t = 3.56, p < 0.001, Fig. 2A). This interaction
as driven by differences between older ValVal and MetMet
ubjects (>50 years) (contrast [1 0 0 0 0 0 −1 0 0 1 0 −1 0 0 0]
eak x,y,z = −12 −8 71, t = 4.42, FWE p < 0.05, Fig. 2C).
his suggests that with aging, subjects with MetMet
enotype had lost grey matter density from the dominant
emisphere premotor region faster than was proportionate
o global atrophy (Fig. 2C). Frontal lobe GM density
id not differ between patients and older controls (con-
rast [1 0 0 1 0 0 1 0 0 −1 −1 −1 0 0 0]) and there were no
ifferences related to linear or quadratic functions of
isease severity (UPDRS) nor PD × genotype interactions
±[1 0 0 0 0 0 −1 0 0 −1 0 1 0 0 0]).
.3. Regionally speciﬁc changes in GM volumeThere were extensive differences between old and
oung healthy subjects, collapsing across the genotypes
[0 0 0 0 0 0 0 0 0 −1 −1 −1 1 1 1], supplementary Fig. S3C).
between age and COMT genotype. (A) GM density differences increasing
01 unc.). Peaks of interest are indicated by the red arrows. (C) GM densities
), ValMet (green) and MetMet (black) groups. (D) GM volume in the left
l (red), ValMet (green) and MetMet (black) groups.
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lder subjects had regional loss of GM volume in the sup-
lementary motor area (1, −13, 73, t = 5.03, FWE p < 0.05),
re-supplementary motor area (1, 20, 64, t = 5.01, FWE
< 0.05) and medial prefrontal cortex (1, 42, 32, t = 7.45,
WE p < 0.05), bilateral polar cortex (±30, 56, 26, t = 4.87,
WE p < 0.05), ventrolateral prefrontal cortex (53,31,−13,
= 5.62, FWE p < 0.05; −54, 19, 28, t = 5.11, FWE p < 0.05)
nd caudate (−3, 6, 7, t = 6.63; 6,9,9,t = 5.22, FWE
< 0.05).
There were weak regional effects of genotype amongst
ealthy subjects ([0 0 0 0 0 0 0 0 0 1 0 −1 1 0 −1], see
upplementary Table S2) and interactions between geno-
ype and age. Specifically, there were bilateral volume
ifferences (ValVal > MetMet) in the anterior insula and
entral frontal cortex in young subjects (young subjects
50 years: ValVal > MetMet difference in the left frontal
perculum/anterior insula, [0 0 0 0 0 0 0 0 0 0 0 0 1 0 −1],
eak −33, 28, 1, t = 4.97, FWE p < 0.05) with an interaction
etween age and genotype ([0 0 0 0 0 0 0 0 0 −1 0 1 1 0 −1]
eak 32, 27,1, t = 4.18, p < 0.001 unc., see Fig. 2B). In
he older subpopulations (>50 years) there were volume
ifferences by genotype (ValVal > MetMet) in left premotor
ortex (−12, −8, 72, t = 4.06, p < 0.001 unc.).
PD was associated with GM volume loss in the medial
rontal cortex (peak −2, 36, 50, t = 4.34, FWE p < 0.05,
upplementary Fig. S3D) extending caudally (at p < 0.001
nc.) to pre-supplementary motor area (5,6,44, t = 3.95) with
dditional peaks in precuneus (−3, −66, 46, t = 3.87) and
isual cortex (−2, −91, 1, t = 3.71). There were no signifi-
ant differences related to the linear or quadratic functions
f disease severity (UPDRS) nor PD × genotype interaction
±[1 0 0 0 0 0 −1 0 0 −1 0 1 0 0 0]).
. Discussion
Global GM volume was greater in young ValVal homozy-
otes consistent with previous reports of Val vs. Met
emizygotes, and despite previous negative reports for adult
omozygotes (Ohnishi et al., 2006; Zinkstok et al., 2006).
owever, our data do not provide evidence of continuing
ifferences in ValVal homozygotes. Instead, the genotype
ffect on global GM diminished with increasing age, sug-
esting that the global developmental differences arising
rom the COMT val158met polymorphism are lost during
dulthood.
These cortical structural differences may contribute to the
omplex changes in executive function with normal aging.
cross the adult age span (35–85 years) ValVal homozygotes
ave a faster decline in executive function over short inter-
als (de Frias et al., 2005) but by old age (>65 years) the
al158met genotype has less influence (de Frias et al., 2005;
tarr et al., 2007). Our data suggest that the loss of this effect
f COMT genotype on executive function with age may be
ue in part to the differential loss of GM although the mecha-
ism for this vulnerability to aging is currently unknown. It is
g
m
d
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ossible that the ValVal associated accelerated atrophy with
ealthy aging is mechanistically associated with the ValVal
ssociated atrophy in schizophrenia (McIntosh et al., 2007;
hnishi et al., 2006) but further work is required to establish
uch a link. However, in contrast to schizophrenia, idiopathic
D did not interact with the effects of val158met COMT
enotype.
We also identified regional differences in the frontal
obes, in terms of GM density and volume related to the
al158met genotype and interactions between age and geno-
ype. These structural differences partially correlate with
egional differences in function. For example, fMRI stud-
es have shown that the val158met polymorphism affects the
rontal activations during tasks of executive function in PD
Williams-Gray et al., 2007) and health (Egan et al., 2001;
eyer-Lindenberg et al., 2005). Typically there is greater
ctivation in lateral or medial prefrontal cortex at equiva-
ent levels of performance for healthy ValVal adults. Of these
egions, the ventral lateral prefrontal cortex is associated with
tructural genotypic differences in grey matter in the current
tudy.
Parietal activity also differs between ValVal and MetMet
dults during some executive tasks (Williams-Gray et al.,
007). However, the current structural data (supplementary
able S2) and previous functional data of regional blood flow
Meyer-Lindenberg et al., 2005) suggest that the parietal dif-
erence is secondary to the frontal effects of genotype, with
ronto-parietal connections, rather than a direct influence on
arietal cortical activity.
Clearly, there are limitations to the study. Our sample size
n = 130) is generally sufficient for VBM but we have several
ubgroups including medicated patients. Although our PD
opulation was larger than most previous VBM studies of
arkinsonian syndromes, and we reproduce VBM effects of
D, we did not find an interaction between disease and COMT
enotype. This might be a false negative result, due to small
ffect size. However, we cannot rule out two further possi-
ilities: a compensatory frontal cortical hyper-dopaminergic
tate in early PD (Rakshi et al., 1999) or that dopaminergic
edication obviates structural changes arising from PD itself.
herefore, independent replication of our findings would
e helpful, especially with unmedicated patients. Finally, it
hould be noted that we have reported the complementary
nformation about human cortical change, including atrophy,
iven by VBM of both modulated and unmodulated brain
mages. However, VBM does not indicate whether these dif-
erences arise from changes to the neuron soma, the neuropil
r even glia.
In summary, our data indicate age-related changes in
lobal and regional grey matter with the val158met polymor-
hism of COMT. These may be of functional significance in
xecutive and affective aspects of cognitive aging. We sug-
est that functional effects of the val158met polymorphism
ay be partly due to differences in the efficacy of current
opamine synaptic transmission, but also differences in local
ortical structure.
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